On November 8, 2021, the US Department of Health and Human Services (HHS) Office of Inspector General (OIG) issued an update to the Health Care Fraud Self-Disclosure Protocol (SDP). This update revises and renames the Provider Self-Disclosure Protocol last updated by OIG in 2013. The changes are mostly procedural in nature and update the SDP based on legislative adjustments to penalty amounts.
Update to Fraud Self-Disclosure Rules for Regulated Healthcare Entities
Posted In Employee Benefits, Health and Welfare Plans

Tony Maida counsels health care and life sciences clients on government investigations, regulatory compliance and compliance program development. Having served as a government official, Tony has extensive experience in health care fraud and abuse and compliance issues, including the federal and state Anti-Kickback and Stark Laws and Medicare and Medicaid coverage and payment rules. He represents clients in False Claims Act (FCA) qui tam matters, government audits, civil monetary penalty and exclusion investigations, and Centers for Medicare and Medicaid Services (CMS) suspension, and revocation actions, negotiating and implementing corporate integrity agreements, and making government self-disclosures. Read Tony Maida's full bio.

Monica A. Wallace focuses her practice on complex regulatory and transactional counseling to healthcare organizations, including health systems, hospitals, ambulatory surgery centers, physician groups, dental providers, integrated delivery systems, academic medical centers, DMEPOS and pharmaceutical manufacturers and suppliers, home health agencies, and venture capital and private equity firms and their health-related portfolio companies. Read Monica Wallace's full bio.

Moyosore (Moyo) O. Koya* works with healthcare clients, particularly hospitals and health systems, on a wide range regulatory and reimbursement issues. Moyo is experienced with federal Medicare and Medicare Advantage plans, including revenue recovery and complex claim reimbursement matters. ReadMoyosore O. Koya's full bio.
Related Posts
- See What’s Next with McDermott+Consulting’s 340B Ligitation Tracking Tool
- Are Out-of-Pocket Costs on Their Way Out? At-Home COVID-19 Testing and Expanded Preventative Healthcare for Women and Children
- Hospitals Push Back Against HHS Slashing of Reimbursement Rates
- Supreme Court Agrees to Review Medicare Payment Cuts to 340B Drugs
- Requirements Related to Surprise Billing: Policy Update
BLOG EDITORS
STAY CONNECTED
TOPICS
ARCHIVES

